Investors & Media

SEC Filing Details

Document Details

Form
Filing Date
Sep 19, 2022
Document Date
Sep 9, 2022
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Sangamo Therapeutics, Inc.
Issuer
SANGAMO THERAPEUTICS, INC
Filer
DUBOIS-STRINGFELLOW NATHALIE